Terms: = Germ cell tumor AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546 AND Prognosis
216 results:
1. A multi-omics analysis-based model to predict the prognosis of low-grade gliomas.
Du Z; Jiang Y; Yang Y; Kang X; Yan J; Liu B; Yang M
Sci Rep; 2024 Apr; 14(1):9427. PubMed ID: 38658591
[TBL] [Abstract] [Full Text] [Related]
2. High-Grade Astrocytoma with Piloid Features: A Dual Institutional Review of Imaging Findings of a Novel Entity.
Soni N; Agarwal A; Ajmera P; Mehta P; Gupta V; Vibhute M; Gubbiotti M; Mark IT; Messina SA; Mohan S; Bathla G
AJNR Am J Neuroradiol; 2024 Apr; 45(4):468-474. PubMed ID: 38485198
[TBL] [Abstract] [Full Text] [Related]
3. Loss of miR-101-3p in melanoma stabilizes genomic integrity, leading to cell death prevention.
Lämmerhirt L; Kappelmann-Fenzl M; Fischer S; Meier P; Staebler S; Kuphal S; Bosserhoff AK
Cell Mol Biol Lett; 2024 Mar; 29(1):29. PubMed ID: 38431560
[TBL] [Abstract] [Full Text] [Related]
4. IDH1 mutation predicts seizure occurrence and prognosis in lower-grade glioma adults.
Tang T; Wang Y; Dai Y; Liu Q; Fan X; Cheng Y; Tang J; Xiao X; Shan Y; Wei P; Zhao G
Pathol Res Pract; 2024 Feb; 254():155165. PubMed ID: 38286053
[TBL] [Abstract] [Full Text] [Related]
5. General Clinico-Pathological Characteristics in Glioblastomas in Correlation with p53 and Ki67.
Sipos TC; Kövecsi A; Ovidiu-Ioan Ș; Zsuzsánna P
Medicina (Kaunas); 2023 Oct; 59(11):. PubMed ID: 38003967
[No Abstract] [Full Text] [Related]
6. A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment.
Alshareefy Y; Cummins S; Mazzoleni A; Sharma V; Guggilapu S; Leong AWY; Wireko AA
Medicine (Baltimore); 2023 Nov; 102(46):e36094. PubMed ID: 37986400
[TBL] [Abstract] [Full Text] [Related]
7. Incidence trends and survival analysis of appendiceal tumors in the United States: Primarily changes in appendiceal neuroendocrine tumors.
Wang D; Ge H; Lu Y; Gong X
PLoS One; 2023; 18(11):e0294153. PubMed ID: 37956190
[TBL] [Abstract] [Full Text] [Related]
8. An immune signature to predict the prognosis of
Cao W; Sun P; Luo S; Zeng Z; Xiao C; Yu W; Lei S
Aging (Albany NY); 2023 Oct; 15(19):10453-10472. PubMed ID: 37812190
[TBL] [Abstract] [Full Text] [Related]
9. Genetic Aspects of Conjunctival Melanoma: A Review.
Chang E; Demirci H; Demirci FY
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
[TBL] [Abstract] [Full Text] [Related]
10. Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using
Lohmeier J; Radbruch H; Brenner W; Hamm B; Tietze A; Makowski MR
J Nucl Med; 2023 Nov; 64(11):1683-1689. PubMed ID: 37652542
[TBL] [Abstract] [Full Text] [Related]
11. Primary mucosal melanomas of the urogenital tract: a clinical, pathological, and genetic nationwide survey of Danish patients 1990-2019.
Znaider VK; Mikkelsen LH; Jensen CFS; Sønksen J; Heegaard S
Scand J Urol; 2023 Aug; 58():52-59. PubMed ID: 37635444
[TBL] [Abstract] [Full Text] [Related]
12. atrx Loss in the Development and prognosis of Conjunctival Melanoma.
van Ipenburg JA; van den Bosch QCC; Paridaens D; Dubbink HJ; Kiliç E; Naus N; Verdijk RM;
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629169
[TBL] [Abstract] [Full Text] [Related]
13. Sirtuin 2 inhibition modulates chromatin landscapes genome-wide to induce senescence in atrx-deficient malignant glioma.
Malgulwar PB; Danussi C; Dharmaiah S; Johnson W; Singh A; Rai K; Rao A; Huse JT
Neuro Oncol; 2024 Jan; 26(1):55-67. PubMed ID: 37625115
[TBL] [Abstract] [Full Text] [Related]
14. Genetic and epigenetic prognosticators of neuroendocrine tumours of the GI tract, liver, biliary tract and pancreas: A systematic review and meta-analysis.
Mestre-Alagarda C; Srirajaskanthan R; Zen Y; Giwa M; Howard M; Ooft ML
Histopathology; 2024 Jan; 84(2):255-265. PubMed ID: 37565289
[TBL] [Abstract] [Full Text] [Related]
15. A threshold for mitotic activity and post-surgical residual volume defines distinct prognostic groups for astrocytoma IDH-mutant.
Tran S; Thomas A; Aliouat I; Karachi C; Lozano F; Mokhtari K; Dehais C; Feuvret L; Carpentier C; Giry M; Doukani A; Lerond J; Marie Y; Sanson M; Idbaih A; Carpentier A; Hoang-Xuan K; Touat M; Capelle L; Bielle F
Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12928. PubMed ID: 37503540
[TBL] [Abstract] [Full Text] [Related]
16. Diagnostic algorithm for pathological evaluation of gliomas in a resource-constrained setting.
Jain S; Gupta P; Shankar KB; Singh R; Siraj F
J Cancer Res Ther; 2023; 19(3):562-566. PubMed ID: 37470575
[TBL] [Abstract] [Full Text] [Related]
17. Differences in survival prognosticators between children and adults with H3K27M-mutant diffuse midline glioma.
Gong X; Kuang S; Deng D; Wu J; Zhang L; Liu C
CNS Neurosci Ther; 2023 Dec; 29(12):3863-3875. PubMed ID: 37311690
[TBL] [Abstract] [Full Text] [Related]
18. Practice of IDH1, atrx, and P53 Immunohistochemistry in Integrated Diagnosis of Adult Diffuse Gliomas: Single Center Study.
Shabanzadeh Nejabad Z; Mabroukzadeh Kavari H; Saffar H; Tavangar SM; Sefidbakht S; Khoshnevisan A; Zare-Mirzaie A; Vasei M; Jafari E; Yaghmaii M; Saffar H
Appl Immunohistochem Mol Morphol; 2023 Jul; 31(6):390-398. PubMed ID: 37278280
[TBL] [Abstract] [Full Text] [Related]
19. Multimodal-based machine learning strategy for accurate and non-invasive prediction of intramedullary glioma grade and mutation status of molecular markers: a retrospective study.
Ma C; Wang L; Song D; Gao C; Jing L; Lu Y; Liu D; Man W; Yang K; Meng Z; Zhang H; Xue P; Zhang Y; Guo F; Wang G
BMC Med; 2023 May; 21(1):198. PubMed ID: 37248527
[TBL] [Abstract] [Full Text] [Related]
20. Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine tumor Liver Metastases: Long-Term Follow-up Evaluation of More Than 500 Patients.
Gudmundsdottir H; Habermann EB; Vierkant RA; Starlinger P; Thiels CA; Warner SG; Smoot RL; Truty MJ; Kendrick ML; Halfdanarson TR; Nagorney DM; Cleary SP
Ann Surg Oncol; 2023 Aug; 30(8):4840-4851. PubMed ID: 37208566
[TBL] [Abstract] [Full Text] [Related]
[Next]
